GENEVA, June 19 -- HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBH filed a patent application (EP2025/071886) for “ENHANCED AND ORTHOGONAL NUCLEIC-ACID DETECTION AND CLEAVAGE USING SPECIFIC CRISPR NUCLEASE SUBSTRATES”. With publication no. WO/2026/104076, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 9/22
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....